
Vanta Bioscience Ltd Releases Annual Report for FY 2024-25
Vanta Bioscience Ltd has released its annual report for the financial year 2024-25. The report, which includes the Notice of the 9th AGM, was sent to members within the stipulated time but inadvertently missed uploading on the Listing Centre. It is now available on the company's website. The report includes the Corporate Information, Board's Report, Management Discussion and Analysis Report, Independent Auditor's Report on Standalone Financial Statements, Standalone Balance Sheet, Standalone Statement of Profit and Loss, Standalone Cash Flows Statement, Notes to the Standalone Financial Statements, Independent Auditors' Report on Consolidated Financial Statements, Consolidated Balance Sheet, Consolidated Statement of Profit and Loss, Consolidated Cash Flows Statement, Notes to the Consolidated Financial Statements, Attendance Slip, Proxy Form, Route Map, and other relevant details.
Key Highlights
- Annual report for FY 2024-25 released
- Includes Notice of the 9th AGM
- Available on the company's website
- Detailed financial statements included
Price Impact
More from VANTABIO
More in Monthly Update